Studies have shown that active fund managers routinely underperform the S&P500 index*​

Biodesix, Inc. (NASDAQ: BDSX)

BDSX Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
14.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-31.70%

BDSX Stock Analysis

BDSX PE Ratio:

BDSX PEG Ratio: Not Available

BDSX Forward EPS Growth (12 month): 0.00%

BDSX PS Ratio: 1.4

BDSX PSG Ratio: 0.1

BDSX Forward Revenue Growth (12 month): 19.60%

BDSX Articles

No data was found